Point Nemo Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Point Nemo Capital's BMY Position: Q2 2026 in Review
Point Nemo Capital opened a new position in Bristol-Myers Squibb (BMY) in Q2 2026: 107 shares worth $6.17K. The stake represents ﹤0.01% of the portfolio and ranks #149 among its holdings. This is a return to the name: Point Nemo Capital previously reported a position in BMY as recently as Q4 2025.
Point Nemo Capital first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. The position peaked at $789K in Q4 2025. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Point Nemo Capital held 107 shares of Bristol-Myers Squibb worth $6.17K as of Q2 2026.
- Bristol-Myers Squibb was a new Point Nemo Capital position in Q2 2026.
- Bristol-Myers Squibb made up ﹤0.01% of Point Nemo Capital's portfolio in Q2 2026, its #149 holding.
- Point Nemo Capital first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
- Point Nemo Capital's Bristol-Myers Squibb position peaked at $789K in Q4 2025.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Point Nemo Capital's 13F filing for Q2 2026, filed 7 Aug 2026.